• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用暴露与反应预防法治疗小儿强迫症时d -环丝氨酸的进展。

Advances in the treatment of pediatric obsessive-compulsive d-cycloserine with exposure and response prevention.

作者信息

McGuire Joseph F, Lewin Adam B, Geller Daniel A, Brown Ashley, Ramsey Kesley, Mutch Jane, Mittelman Andrew, Micco Jamie, Jordan Cary, Wilhelm Sabine, Murphy Tanya K, Small Brent J, Storch Eric A

机构信息

Department of Psychology, University of South Florida, 4202 East Fowler Avenue, Tampa, FL 33620, USA ; Department of Pediactrics, University of South Florida, 880 6th Street South, Suite 460, Box 7523, St Petersburg, FL 33701, USA.

出版信息

Neuropsychiatry (London). 2012 Aug;2(4). doi: 10.2217/npy.12.38.

DOI:10.2217/npy.12.38
PMID:24174993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3808983/
Abstract

Exposure-based cognitive-behavioral therapy and serotonin reuptake inhibitor medications are efficacious treatment options for the management of pediatric obsessive-compulsive disorder. Despite established efficacy, many youths receiving either therapy remain symptomatic after acute treatment. Regardless of the rationale for persistent symptoms, a clear need emerges for treatment options that restore functioning efficiently to symptomatic youths. One innovative approach builds upon the identified role of NMDA receptors in the fear extinction process. Instead of breaking existing connections during fear extinction, new associations develop that eventually predominate over prior associations. Recent investigations have explored augmenting exposure-based cognitive-behavioral therapy with the NMDA partial agonist d-cycloserine, with preliminary results demonstrating expedited treatment gains and moderately larger effects above exposure and response prevention therapy alone. A large randomized clinical trial is underway to evaluate the efficacy and efficiency of this therapeutic combination in pediatric obsessive-compulsive disorder. Results from this trial may translate into improved management practices.

摘要

基于暴露的认知行为疗法和5-羟色胺再摄取抑制剂药物是治疗儿童强迫症的有效选择。尽管已证实其疗效,但许多接受这两种疗法之一的青少年在急性治疗后仍有症状。无论持续出现症状的原因是什么,对于能让有症状的青少年有效恢复正常功能的治疗选择都有明确需求。一种创新方法基于已确定的N-甲基-D-天冬氨酸(NMDA)受体在恐惧消退过程中的作用。在恐惧消退过程中,不是打破现有的联系,而是形成新的关联,最终这些新关联会超过先前的关联。最近的研究探索了用NMDA部分激动剂d-环丝氨酸增强基于暴露的认知行为疗法,初步结果表明,与单独的暴露与反应阻止疗法相比,治疗效果更快,且有适度更大的效果。一项大型随机临床试验正在进行,以评估这种治疗组合在儿童强迫症中的疗效和效果。该试验的结果可能会转化为更好的治疗方法。

相似文献

1
Advances in the treatment of pediatric obsessive-compulsive d-cycloserine with exposure and response prevention.采用暴露与反应预防法治疗小儿强迫症时d -环丝氨酸的进展。
Neuropsychiatry (London). 2012 Aug;2(4). doi: 10.2217/npy.12.38.
2
D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.D-环丝氨酸不能增强强迫症的暴露反应预防疗法。
Int Clin Psychopharmacol. 2007 Jul;22(4):230-7. doi: 10.1097/YIC.0b013e32819f8480.
3
Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial.认知行为疗法联合体重调整的 d-环丝氨酸与安慰剂治疗儿童强迫症的疗效:一项随机临床试验。
JAMA Psychiatry. 2016 Aug 1;73(8):779-88. doi: 10.1001/jamapsychiatry.2016.1128.
4
Cognitive-behavioural therapy with post-session D-cycloserine augmentation for paediatric obsessive-compulsive disorder: pilot randomised controlled trial.认知行为疗法联合治疗后给予 D-环丝氨酸增强治疗儿童强迫症:初步随机对照试验。
Br J Psychiatry. 2014 Jan;204(1):77-8. doi: 10.1192/bjp.bp.113.126284. Epub 2013 Nov 21.
5
d-cycloserine addition to exposure sessions in the treatment of patients with obsessive-compulsive disorder.在强迫症患者治疗中,于暴露疗法期间添加d-环丝氨酸。
Eur Psychiatry. 2017 Feb;40:38-44. doi: 10.1016/j.eurpsy.2016.06.011. Epub 2016 Nov 10.
6
D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial.D-环丝氨酸与安慰剂作为强迫症认知行为治疗的辅助治疗与抗抑郁药的相互作用:一项随机临床试验。
JAMA Psychiatry. 2015 Jul;72(7):659-67. doi: 10.1001/jamapsychiatry.2015.0546.
7
[Psychotherapeutic and pharmacological treatment of pediatric obsessive-compulsive disorder].[儿童强迫症的心理治疗与药物治疗]
Z Kinder Jugendpsychiatr Psychother. 2012 Jan;40(1):29-39; quiz 39-40. doi: 10.1024/1422-4917/a000147.
8
A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.D-环丝氨酸增强认知行为疗法治疗儿童强迫症的初步研究。
Biol Psychiatry. 2010 Dec 1;68(11):1073-6. doi: 10.1016/j.biopsych.2010.07.015.
9
NMDA receptors and fear extinction: implications for cognitive behavioral therapy.N-甲基-D-天冬氨酸受体与恐惧消退:对认知行为疗法的启示
Dialogues Clin Neurosci. 2011;13(4):463-74. doi: 10.31887/DCNS.2011.13.4/mdavis.
10
A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.一项关于认知行为疗法辅助强迫症药物治疗的随机对照试验。
Am J Psychiatry. 2008 May;165(5):621-30. doi: 10.1176/appi.ajp.2007.07091440. Epub 2008 Mar 3.

引用本文的文献

1
Symptom Trajectories of Early Responders and Remitters among Youth with OCD.强迫症青少年中早期应答者和缓解者的症状轨迹
J Obsessive Compuls Relat Disord. 2020 Oct;27. doi: 10.1016/j.jocrd.2020.100580. Epub 2020 Aug 29.
2
Defining Treatment Outcomes in Pediatric Obsessive-Compulsive Disorder Using a Self-Report Scale.使用自报量表定义儿童强迫症的治疗结局。
Behav Ther. 2019 Mar;50(2):314-324. doi: 10.1016/j.beth.2018.06.003. Epub 2018 Jun 22.
3
Quality of Life in Children and Youth with Obsessive-Compulsive Disorder.患有强迫症的儿童和青少年的生活质量
J Child Adolesc Psychopharmacol. 2018 Mar;28(2):104-110. doi: 10.1089/cap.2017.0091. Epub 2017 Sep 14.
4
Fear conditioning and extinction in pediatric obsessive-compulsive disorder.儿童强迫症中的恐惧条件作用与消退
Ann Clin Psychiatry. 2017 Feb;29(1):17-26.
5
Extinction learning in childhood anxiety disorders, obsessive compulsive disorder and post-traumatic stress disorder: implications for treatment.儿童焦虑症、强迫症和创伤后应激障碍中的消退学习:对治疗的启示
Expert Rev Neurother. 2016 Oct;16(10):1155-74. doi: 10.1080/14737175.2016.1199276. Epub 2016 Jun 27.
6
D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysis.D-环丝氨酸增强疗法用于强迫症行为治疗的荟萃分析
Drug Des Devel Ther. 2015 Apr 21;9:2101-17. doi: 10.2147/DDDT.S68994. eCollection 2015.
7
D-cycloserine for treatment of numbing and avoidance in chronic post traumatic stress disorder: A randomized, double blind, clinical trial.D-环丝氨酸治疗慢性创伤后应激障碍中的麻木和回避症状:一项随机、双盲临床试验。
J Res Med Sci. 2014 Jul;19(7):592-8.
8
Enhancing exposure therapy for anxiety disorders, obsessive-compulsive disorder and post-traumatic stress disorder.增强针对焦虑症、强迫症和创伤后应激障碍的暴露疗法。
Expert Rev Neurother. 2014 Aug;14(8):893-910. doi: 10.1586/14737175.2014.934677. Epub 2014 Jun 27.

本文引用的文献

1
D-cycloserine effects on extinction of conditioned responses to drug-related cues.D-环丝氨酸对药物相关线索条件反应消退的影响。
Biol Psychiatry. 2012 Jun 1;71(11):947-55. doi: 10.1016/j.biopsych.2012.02.030.
2
A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder.一项随机安慰剂对照试验研究 D-环丝氨酸增强创伤后应激障碍暴露疗法的效果。
Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. Epub 2012 Apr 4.
3
Antipsychotics in pediatric and adolescent patients: a review of comparative safety data.抗精神病药在儿科和青少年患者中的应用:比较安全性数据综述。
J Affect Disord. 2012;138 Suppl:S22-30. doi: 10.1016/j.jad.2012.02.030. Epub 2012 Mar 8.
4
The nature, assessment, and treatment of obsessive-compulsive disorder.强迫症的性质、评估和治疗。
Postgrad Med. 2012 Jan;124(1):152-65. doi: 10.3810/pgm.2012.01.2528.
5
NMDA receptors and fear extinction: implications for cognitive behavioral therapy.N-甲基-D-天冬氨酸受体与恐惧消退:对认知行为疗法的启示
Dialogues Clin Neurosci. 2011;13(4):463-74. doi: 10.31887/DCNS.2011.13.4/mdavis.
6
Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder.《儿童和青少年强迫症评估和治疗的实践参数》
J Am Acad Child Adolesc Psychiatry. 2012 Jan;51(1):98-113. doi: 10.1016/j.jaac.2011.09.019.
7
A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder.氟西汀联合喹硫平或氯米帕明与氟西汀联合安慰剂治疗强迫症的双盲、随机、对照试验。
J Clin Psychopharmacol. 2011 Dec;31(6):763-8. doi: 10.1097/JCP.0b013e3182367aee.
8
Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial.认知行为疗法联合药物治疗儿童强迫症:儿科强迫症治疗研究 II(POTS II)随机对照试验。
JAMA. 2011 Sep 21;306(11):1224-32. doi: 10.1001/jama.2011.1344.
9
Preliminary investigation of web-camera delivered cognitive-behavioral therapy for youth with obsessive-compulsive disorder.基于网络摄像头的认知行为疗法治疗青少年强迫症的初步研究。
Psychiatry Res. 2011 Oct 30;189(3):407-12. doi: 10.1016/j.psychres.2011.05.047. Epub 2011 Jun 17.
10
Patient utilization of cognitive-behavioral therapy for OCD.强迫症患者对认知行为疗法的利用。
Behav Ther. 2011 Sep;42(3):399-412. doi: 10.1016/j.beth.2010.10.002. Epub 2011 Mar 5.